MALAT1 and myocardial infarction: In this study, we illustrated that M1-BMMs-EV-carried MALAT1 competitively bound to miR-25-3p to promote CDC42 expression and then activated the MEK/ERK pathway, thereby inhibiting angiogenesis and myocardial regeneration following MI (Figure 10).